Breaking News Instant updates and real-time market news.

CSIQ

Canadian Solar

$21.22 /

-0.645 (-2.95%)

07:08
02/10/20
02/10
07:08
02/10/20
07:08

Canadian Solar secures funding for Lavras project in Brazil

Canadian Solar announced it has secured $55M non-recourse project financing from Banco do Nordeste do Brasil S.A. for its Lavras solar power projects. Since the beginning of 2019, Canadian Solar has secured BRL $247M solar project financing with BNB. The 152.4 MWp Lavras project will be funded over 21 years across the construction and operation phases of the projects. The inflation-linked debt tied to the National Consumer Price Index will provide improved capital and resource alignment with the Brazilian economy. Canadian Solar won the Lavras solar project in Brazil's A-4 federal auction in April 2018 with 20-year, inflation-adjusted PPAs awarded at a base price of approximately $29/MWh with the Brazilian Electric Power Commercialization Chamber. The project is expected to start construction in the second quarter of 2020 and reach commercial operation in 2021.

CSIQ Canadian Solar
$21.22 /

-0.645 (-2.95%)

10/07/19 Goldman Sachs
Goldman says U.S. solar makers should benefit from end of bifacial exemption
08/16/19 Roth Capital
Canadian Solar price target raised to $32 from $27 at Roth Capital
04/11/19
Fly Intel: Top five analyst initiations
04/11/19 JPMorgan
Canadian Solar assumed with a Neutral at JPMorgan

TODAY'S FREE FLY STORIES

Conference/Events
GATX participates in a conference call hosted by Sidoti » 07:23
05/27/20
05/27
07:23
05/27/20
07:23
GATX

GATX

$62.11 /

+0.055 (+0.09%)

Conference call with…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GATX GATX
$62.11 /

+0.055 (+0.09%)

GATX GATX
$62.11 /

+0.055 (+0.09%)

GATX GATX
$62.11 /

+0.055 (+0.09%)

Recommendations
PagSeguro Digital price target raised to $32 from $20 at KeyBanc » 07:23
05/27/20
05/27
07:23
05/27/20
07:23
PAGS

PagSeguro Digital

$28.06 /

+1.805 (+6.87%)

KeyBanc analyst Josh Beck…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PAGS PagSeguro Digital
$28.06 /

+1.805 (+6.87%)

05/05/20 Itau BBA
PagSeguro Digital downgraded to Market Perform from Outperform at Itau BBA
04/28/20 Deutsche Bank
PagSeguro Digital price target lowered to $30 from $52 at Deutsche Bank
03/23/20 KeyBanc
PagSeguro Digital price target lowered to $20 from $35 at KeyBanc
02/28/20 Cantor Fitzgerald
PagSeguro Digital price target lowered to $39 from $46 at Cantor Fitzgerald
PAGS PagSeguro Digital
$28.06 /

+1.805 (+6.87%)

Hot Stocks
Gilead to make $200M equity investment in Arcus at a price of $33.54 per share » 07:23
05/27/20
05/27
07:23
05/27/20
07:23
GILD

Gilead

$73.14 /

-0.17 (-0.23%)

, RCUS

Arcus Biosciences

$33.51 /

-2.35 (-6.55%)

Gilead (GILD) and Arcus…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GILD Gilead
$73.14 /

-0.17 (-0.23%)

RCUS Arcus Biosciences
$33.51 /

-2.35 (-6.55%)

GILD Gilead
$73.14 /

-0.17 (-0.23%)

05/26/20 Maxim
ADMA Biologics' use of plasma is 'oldest trick in pandemic playbook', says Maxim
05/26/20 SunTrust
Gilead upgraded to Hold at SunTrust on remdesivir commercial prospects
05/26/20 SunTrust
Gilead upgraded to Hold from Sell at SunTrust
05/26/20 Piper Sandler
Piper Sandler encouraged by remdesivir results published in NEJM
RCUS Arcus Biosciences
$33.51 /

-2.35 (-6.55%)

05/14/20 Mizuho
Arcus Biosciences price target raised to $40 from $22 at Mizuho
05/06/20 Wedbush
Arcus Biosciences price target raised to $40 from $26 at Wedbush
05/06/20 Wedbush
Arcus Biosciences price target raised to $40 from $26 at Wedbush
04/16/20 JonesTrading
Gilead possible stake in Arcus positive for Surface, Infinity, says JonesTrading
GILD Gilead
$73.14 /

-0.17 (-0.23%)

RCUS Arcus Biosciences
$33.51 /

-2.35 (-6.55%)

GILD Gilead
$73.14 /

-0.17 (-0.23%)

RCUS Arcus Biosciences
$33.51 /

-2.35 (-6.55%)

GILD Gilead
$73.14 /

-0.17 (-0.23%)

RCUS Arcus Biosciences
$33.51 /

-2.35 (-6.55%)

GILD Gilead
$73.14 /

-0.17 (-0.23%)

RCUS Arcus Biosciences
$33.51 /

-2.35 (-6.55%)

Downgrade
Acushnet Holdings downgraded to Neutral from Buy at Roth Capital » 07:22
05/27/20
05/27
07:22
05/27/20
07:22
GOLF

Acushnet Holdings

$32.55 /

+1.37 (+4.39%)

Roth Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GOLF Acushnet Holdings
$32.55 /

+1.37 (+4.39%)

GOLF Acushnet Holdings
$32.55 /

+1.37 (+4.39%)

05/19/20 Stephens
Data points to 'encouraging signs' of golf industry demand, says Stephens
04/21/20
Fly Intel: Top five analyst downgrades
04/21/20 Compass Point
With half of U.S. golf courses closed, Compass Point cuts Acushnet to Sell
04/21/20 Compass Point
Acushnet Holdings downgraded to Sell from Neutral at Compass Point
GOLF Acushnet Holdings
$32.55 /

+1.37 (+4.39%)

Recommendations
Twilio price target raised to $240 from $180 at RBC Capital » 07:22
05/27/20
05/27
07:22
05/27/20
07:22
TWLO

Twilio

$195.97 /

-12.67 (-6.07%)

RBC Capital analyst Alex…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TWLO Twilio
$195.97 /

-12.67 (-6.07%)

TWLO Twilio
$195.97 /

-12.67 (-6.07%)

05/26/20 Needham
Twilio price target raised to $225 from $170 at Needham
05/20/20 JMP Securities
Twilio price target raised to $200 from $160 at JMP Securities
05/07/20 DA Davidson
Twilio price target raised to $175 from $144 at DA Davidson
05/07/20 Wells Fargo
Twilio price target raised to $175 from $140 at Wells Fargo
TWLO Twilio
$195.97 /

-12.67 (-6.07%)

TWLO Twilio
$195.97 /

-12.67 (-6.07%)

TWLO Twilio
$195.97 /

-12.67 (-6.07%)

TWLO Twilio
$195.97 /

-12.67 (-6.07%)

Hot Stocks
Gilead, Arcus Biosciences establish 10-year cancer immunotherapies partnership » 07:20
05/27/20
05/27
07:20
05/27/20
07:20
GILD

Gilead

$73.14 /

-0.17 (-0.23%)

, RCUS

Arcus Biosciences

$33.51 /

-2.35 (-6.55%)

Gilead Sciences (GILD)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GILD Gilead
$73.14 /

-0.17 (-0.23%)

RCUS Arcus Biosciences
$33.51 /

-2.35 (-6.55%)

GILD Gilead
$73.14 /

-0.17 (-0.23%)

05/26/20 Maxim
ADMA Biologics' use of plasma is 'oldest trick in pandemic playbook', says Maxim
05/26/20 SunTrust
Gilead upgraded to Hold at SunTrust on remdesivir commercial prospects
05/26/20 SunTrust
Gilead upgraded to Hold from Sell at SunTrust
05/26/20 Piper Sandler
Piper Sandler encouraged by remdesivir results published in NEJM
RCUS Arcus Biosciences
$33.51 /

-2.35 (-6.55%)

05/14/20 Mizuho
Arcus Biosciences price target raised to $40 from $22 at Mizuho
05/06/20 Wedbush
Arcus Biosciences price target raised to $40 from $26 at Wedbush
05/06/20 Wedbush
Arcus Biosciences price target raised to $40 from $26 at Wedbush
04/16/20 JonesTrading
Gilead possible stake in Arcus positive for Surface, Infinity, says JonesTrading
GILD Gilead
$73.14 /

-0.17 (-0.23%)

RCUS Arcus Biosciences
$33.51 /

-2.35 (-6.55%)

GILD Gilead
$73.14 /

-0.17 (-0.23%)

RCUS Arcus Biosciences
$33.51 /

-2.35 (-6.55%)

GILD Gilead
$73.14 /

-0.17 (-0.23%)

RCUS Arcus Biosciences
$33.51 /

-2.35 (-6.55%)

GILD Gilead
$73.14 /

-0.17 (-0.23%)

RCUS Arcus Biosciences
$33.51 /

-2.35 (-6.55%)

Hot Stocks
McDonald's UK: 1,020 restaurants to have reopened by June 4 » 07:19
05/27/20
05/27
07:19
05/27/20
07:19
MCD

McDonald's

$184.88 /

+0.29 (+0.16%)

McDonald's UK…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MCD McDonald's
$184.88 /

+0.29 (+0.16%)

MCD McDonald's
$184.88 /

+0.29 (+0.16%)

05/26/20 JPMorgan
McDonald's price target raised to $180 from $172 at JPMorgan
05/26/20 JPMorgan
Chipotle price target raised to $845 from $630 at JPMorgan
05/26/20 Longbow
McDonald's price target raised to $210 from $197 at Longbow
05/18/20 BTIG
Beyond Meat started with a Buy at BTIG on potential partnerships major chains
MCD McDonald's
$184.88 /

+0.29 (+0.16%)

MCD McDonald's
$184.88 /

+0.29 (+0.16%)

MCD McDonald's
$184.88 /

+0.29 (+0.16%)

MCD McDonald's
$184.88 /

+0.29 (+0.16%)

Periodicals
Volkswagen in discussions to seal deals with Chinese EV companies, Reuters says » 07:19
05/27/20
05/27
07:19
05/27/20
07:19
VWAGY

Volkswagen

$0.00 /

+ (+0.00%)

Volkswagen is in final…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VWAGY Volkswagen
$0.00 /

+ (+0.00%)

VWAGY Volkswagen
$0.00 /

+ (+0.00%)

05:41 Today MainFirst
Volkswagen initiated with a Hold at MainFirst
05/26/20 JMP Securities
Cree upgraded to Outperform from Market Perform at JMP Securities
04/30/20 JPMorgan
Volkswagen price target raised to EUR 150 from EUR 116 at JPMorgan
03/26/20 RBC Capital
Volkswagen price target raised to EUR 175 from EUR 165 at RBC Capital
VWAGY Volkswagen
$0.00 /

+ (+0.00%)

VWAGY Volkswagen
$0.00 /

+ (+0.00%)

VWAGY Volkswagen
$0.00 /

+ (+0.00%)

Hot Stocks
Endeavour Mining publishes sustainability report » 07:18
05/27/20
05/27
07:18
05/27/20
07:18
EDVMF

Endeavour Mining

$0.00 /

+ (+0.00%)

Endeavour Mining…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EDVMF Endeavour Mining
$0.00 /

+ (+0.00%)

EDVMF Endeavour Mining
$0.00 /

+ (+0.00%)

05/19/20 National Bank
Endeavour Mining price target raised to C$42 from C$36 at National Bank
05/04/20 Berenberg
Endeavour Mining price target raised to C$34 from C$31 at Berenberg
04/17/20 RBC Capital
Endeavour Mining price target raised to C$36 from C$34 at RBC Capital
04/02/20 RBC Capital
RBC Capital maintains Outperform on Endeavour Mining
Recommendations
Piedmont Lithium price target lowered to $20 from $28 at Roth Capital » 07:17
05/27/20
05/27
07:17
05/27/20
07:17
PLL

Piedmont Lithium

$7.76 /

-0.01 (-0.13%)

Roth Capital analyst Joe…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PLL Piedmont Lithium
$7.76 /

-0.01 (-0.13%)

Initiation
Nordex initiated with a Buy at Jefferies » 07:17
05/27/20
05/27
07:17
05/27/20
07:17
NRDXF

Nordex

$0.00 /

+ (+0.00%)

Jefferies analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Periodicals
Moderna executives have sold more than $89M of stock this year, StatNews says » 07:16
05/27/20
05/27
07:16
05/27/20
07:16
MRNA

Moderna

$57.73 /

-11.27 (-16.33%)

Moderna's top five…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MRNA Moderna
$57.73 /

-11.27 (-16.33%)

MRNA Moderna
$57.73 /

-11.27 (-16.33%)

05/26/20 Maxim
ADMA Biologics' use of plasma is 'oldest trick in pandemic playbook', says Maxim
05/20/20 Morgan Stanley
Moderna price target raised to $90 from $37 at Morgan Stanley
05/19/20 Piper Sandler
Piper trims Moderna target to $100 on capital raise dilution
05/19/20 BMO Capital
Moderna price target raised to $112 from $83 at BMO Capital
MRNA Moderna
$57.73 /

-11.27 (-16.33%)

MRNA Moderna
$57.73 /

-11.27 (-16.33%)

MRNA Moderna
$57.73 /

-11.27 (-16.33%)

MRNA Moderna
$57.73 /

-11.27 (-16.33%)

Upgrade
CNP Assurances upgraded to Buy from Hold at HSBC » 07:15
05/27/20
05/27
07:15
05/27/20
07:15
CNPAY

CNP Assurances

$0.00 /

+ (+0.00%)

HSBC analyst Thomas…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CNPAY CNP Assurances
$0.00 /

+ (+0.00%)

02/05/20 Exane BNP Paribas
CNP Assurances upgraded to Neutral from Underperform at Exane BNP Paribas
Hot Stocks
Medipharm, Argentia Gold to bring cannabis-infused products to Atlantic Canada » 07:14
05/27/20
05/27
07:14
05/27/20
07:14
MEDIF

Medipharm Labs

$0.00 /

+ (+0.00%)

MediPharm Labs and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MEDIF Medipharm Labs
$0.00 /

+ (+0.00%)

MEDIF Medipharm Labs
$0.00 /

+ (+0.00%)

08/07/19 Roth Capital
Medipharm Labs initiated with a Buy at Roth Capital
MEDIF Medipharm Labs
$0.00 /

+ (+0.00%)

MEDIF Medipharm Labs
$0.00 /

+ (+0.00%)

Earnings
Euroseas reports Q1 adj. EPS 17c, two est. 36c » 07:12
05/27/20
05/27
07:12
05/27/20
07:12
ESEA

Euroseas

$2.33 /

+0.03 (+1.30%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ESEA Euroseas
$2.33 /

+0.03 (+1.30%)

ESEA Euroseas
$2.33 /

+0.03 (+1.30%)

Recommendations
AutoZone price target raised to $1,105 from $967 at Goldman Sachs » 07:11
05/27/20
05/27
07:11
05/27/20
07:11
AZO

AutoZone

$1,123.19 /

+3.81 (+0.34%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AZO AutoZone
$1,123.19 /

+3.81 (+0.34%)

AZO AutoZone
$1,123.19 /

+3.81 (+0.34%)

06:27 Today Nomura Instinet
AutoZone price target raised to $1,290 from $1,210 at Nomura Instinet
05/20/20 Nomura Instinet
AutoZone price target raised to $1,210 from $1,031 at Nomura Instinet
05/15/20 Cleveland Research
O'Reilly, AutoZone, Advance appear to be gaining share, says Cleveland Research
05/14/20 Wells Fargo
AutoZone price target raised to $1,175 from $1,050 at Wells Fargo
AZO AutoZone
$1,123.19 /

+3.81 (+0.34%)

AZO AutoZone
$1,123.19 /

+3.81 (+0.34%)

AZO AutoZone
$1,123.19 /

+3.81 (+0.34%)

Hot Stocks
BioLineRx's ongoing COMBAT trial featured in peer-reviewed journal » 07:11
05/27/20
05/27
07:11
05/27/20
07:11
BLRX

BioLineRx

$1.63 /

-0.76 (-31.80%)

BioLineRx announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BLRX BioLineRx
$1.63 /

-0.76 (-31.80%)

BLRX BioLineRx
$1.63 /

-0.76 (-31.80%)

03/13/20 Oppenheimer
BioLineRx price target lowered to $11 from $26 at Oppenheimer
BLRX BioLineRx
$1.63 /

-0.76 (-31.80%)

Hot Stocks
Papa John's reports April, May period comparable sales » 07:09
05/27/20
05/27
07:09
05/27/20
07:09
PZZA

Papa John's

$74.13 /

-3.58 (-4.61%)

The company reports April…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PZZA Papa John's
$74.13 /

-3.58 (-4.61%)

PZZA Papa John's
$74.13 /

-3.58 (-4.61%)

05/14/20 Northcoast
Papa John's sustaining strong comp growth as states reopen, says Northcoast
05/07/20 Stephens
Papa John's price target raised to $83 from $61 at Stephens
05/07/20 Credit Suisse
Papa John's price target raised to $84 from $71 at Credit Suisse
05/01/20 Northcoast
Papa John's downgraded to Neutral from Buy at Northcoast
PZZA Papa John's
$74.13 /

-3.58 (-4.61%)

PZZA Papa John's
$74.13 /

-3.58 (-4.61%)

PZZA Papa John's
$74.13 /

-3.58 (-4.61%)

Hot Stocks
RedHill Biopharma planning development path toward RHB-106 approval in U.S. » 07:09
05/27/20
05/27
07:09
05/27/20
07:09
RDHL

RedHill Biopharma

$7.17 /

-0.23 (-3.11%)

In January 2020, RedHill…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RDHL RedHill Biopharma
$7.17 /

-0.23 (-3.11%)

RDHL RedHill Biopharma
$7.17 /

-0.23 (-3.11%)

02/27/20 Roth Capital
RedHill Biopharma price target lowered to $15 from $20.25 at Roth Capital
07/12/19 WBB Securities
RedHill Biopharma upgraded to Strong Buy from Buy at WBB Securities
RDHL RedHill Biopharma
$7.17 /

-0.23 (-3.11%)

Hot Stocks
RedHill Biopharma continues to advance development program for MAP bacteria » 07:09
05/27/20
05/27
07:09
05/27/20
07:09
RDHL

RedHill Biopharma

$7.17 /

-0.23 (-3.11%)

RedHill announced in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RDHL RedHill Biopharma
$7.17 /

-0.23 (-3.11%)

RDHL RedHill Biopharma
$7.17 /

-0.23 (-3.11%)

02/27/20 Roth Capital
RedHill Biopharma price target lowered to $15 from $20.25 at Roth Capital
07/12/19 WBB Securities
RedHill Biopharma upgraded to Strong Buy from Buy at WBB Securities
RDHL RedHill Biopharma
$7.17 /

-0.23 (-3.11%)

Syndicate
Silicon Labs files to sell $500M of Convertible Senior Notes due 2025  07:09
05/27/20
05/27
07:09
05/27/20
07:09
SLAB

Silicon Labs

$95.84 /

+1.56 (+1.65%)

 
ShowHide Related Items >><<
SLAB Silicon Labs
$95.84 /

+1.56 (+1.65%)

SLAB Silicon Labs
$95.84 /

+1.56 (+1.65%)

04/30/20 Cowen
Silicon Labs price target raised to $115 from $100 at Cowen
04/06/20
Fly Intel: Top five analyst initiations
04/06/20 SMBC Nikko
Silicon Labs initiated with a Neutral at SMBC Nikko
03/13/20 Needham
Silicon Labs price target lowered to $100 from $115 at Needham
SLAB Silicon Labs
$95.84 /

+1.56 (+1.65%)

Hot Stocks
RedHill Biopharma plans to add third arm to Phase 2a study of opaganib » 07:08
05/27/20
05/27
07:08
05/27/20
07:08
RDHL

RedHill Biopharma

$7.17 /

-0.23 (-3.11%)

RedHill has completed the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RDHL RedHill Biopharma
$7.17 /

-0.23 (-3.11%)

RDHL RedHill Biopharma
$7.17 /

-0.23 (-3.11%)

02/27/20 Roth Capital
RedHill Biopharma price target lowered to $15 from $20.25 at Roth Capital
07/12/19 WBB Securities
RedHill Biopharma upgraded to Strong Buy from Buy at WBB Securities
RDHL RedHill Biopharma
$7.17 /

-0.23 (-3.11%)

Recommendations
H.C. Wainwright ups Durect target to $6 on positive NASH data » 07:08
05/27/20
05/27
07:08
05/27/20
07:08
DRRX

Durect

$2.66 /

+0.19 (+7.69%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DRRX Durect
$2.66 /

+0.19 (+7.69%)

DRRX Durect
$2.66 /

+0.19 (+7.69%)

05/12/20 Cantor Fitzgerald
Durect risk/reward 'highly favorable' into Posimir decision, says Cantor
03/04/20 Cantor Fitzgerald
Cantor reiterates Overweight on Durect with $5 target post results
01/31/20 B. Riley FBR
B. Riley FBR starts Durect with Buy rating, $5 price target
01/31/20 B. Riley FBR
Durect initiated with a Buy at B. Riley FBR
DRRX Durect
$2.66 /

+0.19 (+7.69%)

DRRX Durect
$2.66 /

+0.19 (+7.69%)

DRRX Durect
$2.66 /

+0.19 (+7.69%)

DRRX Durect
$2.66 /

+0.19 (+7.69%)

Hot Stocks
RedHill Biopharma plans to initiate Phase 3 study of RHB-204 in Q3 » 07:07
05/27/20
05/27
07:07
05/27/20
07:07
RDHL

RedHill Biopharma

$7.17 /

-0.23 (-3.11%)

Following recent data…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RDHL RedHill Biopharma
$7.17 /

-0.23 (-3.11%)

RDHL RedHill Biopharma
$7.17 /

-0.23 (-3.11%)

02/27/20 Roth Capital
RedHill Biopharma price target lowered to $15 from $20.25 at Roth Capital
07/12/19 WBB Securities
RedHill Biopharma upgraded to Strong Buy from Buy at WBB Securities
RDHL RedHill Biopharma
$7.17 /

-0.23 (-3.11%)

Hot Stocks
Compugen doses first patient in COM701 Phase 1 monotherapy expansion cohort » 07:06
05/27/20
05/27
07:06
05/27/20
07:06
CGEN

Compugen

$14.28 /

-0.02 (-0.14%)

Compugen announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CGEN Compugen
$14.28 /

-0.02 (-0.14%)

CGEN Compugen
$14.28 /

-0.02 (-0.14%)

05/26/20 JMP Securities
Compugen resumed with an Outperform at JMP Securities
05/13/20
Fly Intel: Top five analyst initiations
05/13/20 Stifel
Compugen initiated with a Buy at Stifel
05/07/20
Fly Intel: Top five analyst initiations
CGEN Compugen
$14.28 /

-0.02 (-0.14%)

CGEN Compugen
$14.28 /

-0.02 (-0.14%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.